MBX Biosciences (MBX) Shares Issued (2023 - 2026)

MBX Biosciences has disclosed Shares Issued across 4 years of filings, most recently posting $2.4 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $2.4 million, up 60950.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 1018.35% YoY), and the FY2024 annual result was $403000.0, down 45.47% from the prior year.
• Shares Issued came in at $2.4 million for Q1 2026 at MBX Biosciences, up from -$1.3 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $2.4 million in Q1 2026 to a low of -$1.3 million in Q3 2025.
• The 4-year median for Shares Issued is $189000.0 (2024), against an average of $398222.2.
• Across the five-year window, Shares Issued sank 4190.32% in 2025 and surged 60950.0% in 2026, its largest moves.
• MBX Biosciences' Shares Issued stood at $739000.0 in 2023, then plunged by 73.61% to $195000.0 in 2024, then slumped by 782.05% to -$1.3 million in 2025, then soared by 283.61% to $2.4 million in 2026.
• The last three Shares Issued figures came in at $2.4 million (Q1 2026), -$1.3 million (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.